Heart disease, clinical proteomics and mass spectrometry

Disease Markers

Volumn 20, Issue 3, 2004, Pages 167-178

  Stanley, Brian A ^a,b   Gundry, Rebekah L ^a   Cotter, Robert J ^a   Van Eyk, Jennifer E ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; TROPONIN I;

ACUTE HEART INFARCTION; CARDIOPULMONARY HEMODYNAMICS; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DISEASE MARKER; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORBIDITY; MORTALITY; MUSCLE CELL; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; RISK; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 4744351348     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/965261     Document Type: Review

References (39)

1. N. Ahmed, G. Barker et al., An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum, Proteomics 3 (2003), 1980-1987.
2. F.S. Apple, M.M. Murakami et al., Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease, Circulation 106 (2002), 2941-2945.
3. F.S. Apple, A.H. Wu et al., European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials, Am Heart J 144 (2002), 981-986.
4. P. Ardelt, P. Dorka et al., Microanalysis and distribution of cardiac troponin I phospho species in heart areas, Biol Chem 379 (1998), 341-347.
5. A.H. Association, Heart Disease and Stroke Statistics - 2004 Update, A. H. Association.
6. U. Bilitewski, M. Genrich et al., Biochemical analysis with microfluidic systems, Anal Bioanal Chem 377 (2003), 556-569.
7. H. Brzeski, R.A. Katenhusen et al., Albumin depletion method for improved plasma glycoprotein analysis by two-dimensional difference gel electrophoresis, Biotechniques 35 (2003), 1128-1132.
8. D.J. Cahill, E. Nordhoff, Protein arrays and their role in proteomics, Adv Biochem Eng Biotechnol 83 (2003), 177-187.
9. D.A. Colantonio, W. Pickett et al., Detection of cardiac troponin I early after onset of chest pain in six patients, Clin Chem 48 (2002), 668-671.
10. T.J. Cornish, R.J. Cotter, A curved-field reflectron for improved energy focusing of product ions in time-of-flight mass spectrometry, Rapid Commun Mass Spectrom 7 (1993), 1037-1040.
11. B. Dayal, N.H. Ertel, ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease, J Proteome Res 1 (2002), 375-380.
12. Ding, R. Labugger et al., Development of an Interaction Discovery Mapping? Methodology for Assessing Myocardial Infarction Severity using SELDI-TOF Mass Spectrometry, A.A.C.C.
13. E. Gianazza, P. Arnaud, Chromatography of plasma proteins on immobilized Cibacron Blue F3-GA. Mechanism of the molecular interaction, Biochem J 203 (1982), 637-641.
14. I. Giuliani, J.P. Bertinchant et al., Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia, Clin Chem 45 (1999), 213-222.
15. I. Giuliani, J.P. Bertinchant et al., Determination of cardiac troponin I forms in the blood of patients with unstable angina pectoris, Clin Biochem 35 (2002), 111-117.
16. N.I. Govorukhina, A. Keizer-Gunnink et al., Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion, J Chromatogr A 1009 (2003), 171-178.
17. C.B. Granger, J.E. Van Eyk et al., NHLCI clinical proteomics working group report, Circulation In Press, 2004.
18. W.J. Henzel, T.M. Billed et al., Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases, Proc Natl Acad Sci USA 90 (1993), 5011-5015.
19. A.G. Katrukha, A.V. Bereznikova et al., Degradation of cardiac troponin I: implication for reliable immunodetection, CLin Chem 44 (1998), 2433-2440.
20. L.J. Kricka, T. Joos et al., Protein microarrays: a literature survey, Clin Chem 49 (2003), 2109.
21. R. Labugger, L. Organ et al., Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction, Circulation 102 (2000), 1221-1226.
22. R. Labugger, J.A. Simpson et al., Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry, Clin Chem 49 (2003), 873-879.
23. P. Lecchi, A.R. Gupte et al., Size-exclusion chromatog raphy in multidimensional separation schemes for proteome analysis, J Biochem Biophys Methods 56 (2003), 141-152.
24. Y. Lee, E.K. Lee et al., ProteoChip: a highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein-protein interaction studies, Proteomics 3 (2003), 2289-2304.
25. A. Lueking, A. Possling et al., A Nonredundant Human Protein Chip for Antibody Screening and Serum Profiling, Mol Cell Proteomics 2 (2003), 1342-1349.
26. K. Millea, I. Krull, Subproteomics in Analytical Chemistry: Chromatographic Fractionation Techniques in the Characterization of Proteins and Peptides, J Liq Chromatogr 26 (2003), 2195-2224.
27. G.J. Opiteck, S.M. Ramirez et al., Comprehensive two-dimensional high-performance liquid chromatography for the isolation of overexpressed proteins and proteome mapping, Anal Biochem 258 (1998), 349-361.
28. Z. Ouyang, Z. Takats et al., Preparing protein microarrays by soft-landing of mass-selected ions, Science 301 (2003), 1351-1354.
29. R. Pieper, Q. Su et al., Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome, Proteomics 3 (2003), 422-432.
30. A. Ressine, S. Ekstrom et al., Macro-/nanoporous silicon as a support for high-performance protein microarrays, Anal Chem 75 (2003), 6968-6974.
31. J.P. Salier, P. Rouet et al., The inter-alpha-inhibitor family: from structure to regulation, Biochem J 315(Pt 1) (1996), 1-9.
32. S.Y. Seong, C.Y. Choi, Current status of protein chip development in terms of fabrication and application, Proteomics 3 (2003), 2176-2189.
33. Y. Shen, R.D. Smith, Proteomics based on high-efficiency capillary separations, Electrophoresis 23 (2002), 3106-3124.
34. J.A. Simpson, S. Iscoe et al., Myofilament proteomics: unraveling contractile dysfunction, in: Genomic and Proteomic Analysis of Cardiovascular Disease: molecular mechanism, therapeutic targets and diagnostics, Wiley and Son, eds, Germany, 2003, pp. 317-342.
35. L.F. Steel, M.G. Trotter et al., Efficient and specific removal of albumin from human serum samples, Mol Cell Proteomics 2 (2003), 262-270.
36. N. Tang, P. Tornatore et al., Current developments in SELDI affinity technology, Mass Spectrom Rev 23 (2004), 34-44.
37. Z.H. Wang, G. Jin, A label-free multisensing immunosensor based on imaging ellipsometry, Anal Chem 75 (2003), 6119-6123.
38. A.H. Wu, Y.J. Feng et al., Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization, Clin Chem 44 (1998), 1198-1208.
39. R. Zhang, L. Barker et al., Mining biomarkers in human sera using proteomic tools, Proteomics 4 (2004), 244-256.